September 2026 Catalyst Probability/Move Analysis
46 minutes ago
3 min read
We've been working with BPIQ-AI to provide more info about upcoming catalysts to help provide more info for investors to consider in their diligence of smid-cap biopharma companies. The table below shows BPIQ AI's predicted probabilities(FN1) for September 2026 Phase 2 and Phase 3 clinical trial readouts, that an event will readout as a clean positive or negative, or with mixed data. And its predicted magnitude of move for those. Keep in mind of course, that predicting catalysts is moves is very complicated and we are still working with our BPIQ AI to improve its predictions.
